Onconetix
ONCO----
Onconetix (ONCO)
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United S...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Onconetix Analyst Rating
View MoreForecast & Rating
Oct 25, 2023Price forecast
$1530000.76186312706.26%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 22 at 10:25 AM
Realbotix outlines holding-company structure with separate commercial robotics, DTC adult wellness units
- Price Alert · Jul 7 at 08:07 AM
Pre-market hot trades in US stocks: Digitalocean up 15.32% in pre-market; Onconetix down 11.15% in pre-market
- PUBT · Jul 7 at 08:02 AM
Onconetix says Realbotix acquisition expected to close in H2 2026
- Unusual Whales · Jul 7 at 08:02 AM
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
- Price Alert · Jul 1 at 08:12 AM
Pre-market hot trades in US stocks: Onconetix pre-market down 7.08%; MaxLinear pre-market down 7.05%
- PUBT · Jun 30 at 05:00 PM
Onco-Innovations starts polymer process development, characterization program for ONC010 nanoparticle PNKP inhibitor
